Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CACNA1H mutations in autism spectrum disorders.

Igor Splawski1, Dana S Yoo1, Stephanie C Stotz2

  • 1Howard Hughes Medical Institute, Department of Cardiology, Children's Hospital, Departments of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115; Cell Biology, Harvard Medical School, Boston, Massachusetts 02115.

The Journal of Biological Chemistry
|June 7, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource.

Nature·2026
Same author

Phenotypic CRISPR screens identify NLRX1 as an essential activator of the human mitochondrial permeability transition.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell function.

Diabetologia·2025
Same author

Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studies.

Lancet (London, England)·2025
Same author

An ANGPTL4 inhibitory antibody safely improves lipid profiles in non-human primates.

EBioMedicine·2025
Same author

Periodic ER-plasma membrane junctions support long-range Ca<sup>2+</sup> signal integration in dendrites.

Cell·2024

Genetic variations in the CACNA1H gene, affecting T-type calcium channels, were found in individuals with autism spectrum disorder (ASD). These mutations may impact neuronal function and contribute to ASD development.

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Autism spectrum disorder (ASD) is a neurodevelopmental condition with largely unknown genetic causes.
  • Previous research linked CACNA1C (L-type Ca(V)1.2) calcium channel mutations to a disorder associated with autism.

Purpose of the Study:

  • To investigate the role of calcium channel gene CACNA1H in the etiology of autism spectrum disorder.

Main Methods:

  • Screening of the CACNA1H gene in 461 individuals diagnosed with ASD.
  • Genotyping of 480 ethnically matched controls to assess mutation prevalence.
  • Functional analysis of identified CACNA1H mutations to evaluate their impact on Ca(V)3.2 channel activity.

Main Results:

Related Experiment Videos

  • Missense mutations in CACNA1H (T-type Ca(V)3.2) were identified in 6 out of 461 individuals with ASD.
  • These mutations were significantly more prevalent in the ASD cohort compared to controls (p = 0.014).
  • Functional studies demonstrated that all identified mutations markedly reduced Ca(V)3.2 channel activity.

    • Conclusions:

    • Mutations in CACNA1H may contribute to the development of ASD.
    • Reduced Ca(V)3.2 channel activity due to these mutations could affect neuronal function and brain development.
    • While not solely causative, these mutations represent a potential genetic risk factor for ASD.